Although this study did not deepen our understanding of the molecular mechanisms behind these positive effects, the anti-obesity properties of this drug offer interesting ways to study GSDMD function in highly metabolic tissues affected by obesity, as in the case of skeletal muscle. Here, GSDMD is linked to obesity due to melanocortin 4 receptor deficiency.